Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Cardinal Health (NY: CAH )

120.56 +2.34 (+1.98%)
Official Closing Price Updated: 7:00 PM EST, Nov 8, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Cardinal Health

< Previous 1 2
...
6 7 8 9 10 11 12 13 Next >
McDonald's Bolsters Digital Vision With New Senior Appointment
Via Benzinga
RxLive Raises $5 Million Series A to Deliver Population Health Telepharmacy Solutions for At-Risk Patients
Digital Health Startup Is Tackling Medication Mismanagement, a $500 Billion Problem 
From RxLive
Via GlobeNewswire
Cardinal Health Stock Earns Relative Strength Rating Upgrade; Hits Key Threshold
Cardinal Health sees its Relative Strength Rating enter the 80-plus level. 
Via Investor's Business Daily
Why McKesson Just Added To Its 33% Year-To-Date Gain With A Brief Breakout
This red-hot stock leads its industry group, is highly rated and topped a buy point. 
Via Investor's Business Daily
Cardinal Health's Shares Fall as Inflation and Supply Chain Constraints Hit Q3 Earnings
Via Benzinga
Cardinal Health: Q3 Earnings Insights
Cardinal Health (NYSE:CAH) reported its Q3 earnings results on Thursday, May 5, 2022 at 06:45 AM. Here's what investors need to know about the announcement. 
Via Benzinga
Should Value Investors Pick Cardinal Health (CAH) Stock Now?
Cardinal Health is an inspired choice for value investors, as it is hard to beat its incredible lineup of statistics on this front. 
Via Talk Markets
What 4 Analyst Ratings Have To Say About Cardinal Health
Within the last quarter, Cardinal Health (NYSE:CAH) has observed the following analyst ratings: 
Via Benzinga
New York Attorney General Says Teva Tried To Evade Accountability On Opioid Crisis: Report
Reuters reported that New York's attorney general said Teva Pharmaceutical Industries Ltd (NY 
Via Benzinga
Is J&J Stock A Buy On Its Recent Spate Of Positive Cancer News?
Johnson & Johnson is less focused on Covid and more focused on cancer in 2022. 
Via Investor's Business Daily
Benzinga Before The Bell: Record Inflows In 'Short Bitcoin' Funds, Elon Mus's Trillionaire Possibility, Gmail's Political Bias And Other Top Financial Stories Tuesday, July 5
Reuters 
Via Benzinga
Federal Judge Says McKesson, AmerisourceBergen, Cardinal Health Not Responsible For Opioid Epidemic: Report
Via Benzinga
Quant Ratings Updated on 97 Stocks
Over the weekend, I revised my Portfolio Grader recommendations for 97 blue-chip stocks, and many of them were in the tech industry 
Via InvestorPlace
SciSparc And Polyrizon Report Joining Forces To Develop A Non-Opioid Pain Relief Nasal Spray
The opioid crisis has raised public awareness about the dire state of pain-management options for the estimated 50 million Americans with chronic pain. 
Via Benzinga
7 High-Yield Retirement Stocks to Buy for Your Nest Egg
These 7 high-yield retirement stocks to buy are among a list of companies that are dividend aristocrats and offer great dividends. 
Via InvestorPlace
7 Beaten-Down Growth Stocks That Look Like Big Bargains Right Now
These beaten-down growth stocks look like big bargains as they are now heavily oversold despite their reassuring prospects. 
Via InvestorPlace
Benzinga's Top Ratings Upgrades, Downgrades For May 26, 2022
Upgrades 
Via Benzinga
The 7 Highest-Yielding Dividend Stocks to Buy Now for Income
These are the highest-yielding dividend stocks to invest in now. Each company offers investors a gateway to tap into significant yields. 
Via InvestorPlace
Benzinga's Top Ratings Upgrades, Downgrades For May 18, 2022
Via Benzinga
Dividend Income Update April 2022
With May already underway it is time for all dividend income investors to look back at the previous month and see how much passive dividend income their portfolios generated. 
Via Talk Markets
7 Stock Picks to Play the Post-Pandemic Return of Dental Visits
The two years away from the “chair” could cynically boost these oral health plays. 
Via InvestorPlace
Walgreens Announces $683M Opioid Settlement With Florida
Via Benzinga
Washington, Drug Distributors Reach $518M Settlement For Opioid Claims
Via Benzinga
Distributors Agree to Opioid Settlement With Washington State
From McKesson Corporation
Via Business Wire
San Francisco To Start Opioid Epidemic Trial Against Teva, Walgreen: Reuters
Via Benzinga
President Biden To Outline Strategy To Tackle Drug Addiction, Overdose: Reuters
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For April 12, 2022
Upgrades 
Via Benzinga
10 Stocks That Moved From Thursday's CNBC's 'Fast Money: Halftime Report'
CNBC’s "Fast Money: Halftime Report" delivers market-moving news to investors. 
Via Benzinga
Hostess Brands Appoints Travis Leonard As Finance Chief
Hostess Brands Inc (NASDAQ: TWNK) has appointed Travis Leonard as the Chief Financial Officer (CFO), effective May 11, 2022. Leonard will succeed interim CFO... 
Via Benzinga
West Virginia Says J&J, Teva, AbbVie Caused 'Tsunami' Of Opioid Addiction: Reuters
West Virginia's attorney general urged a judge to hold Johnson & Johnson (NYSE: JNJ), Teva Pharmaceuticals Industries Ltd (NYSE: TEVA), and AbbVie Inc's (NYSE: 
Via Benzinga
< Previous 1 2
...
6 7 8 9 10 11 12 13 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.